$1.28
0.010.79%
At Close: -
$1.26
-0.02-1.57%
After Hours: 8:48 AM EDT
15 minutes delayed
Clearside Biomedical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Clearside Biomedical using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
CLSD | Clearside Biomedical | -$0.15 | -$0.13 | — | — | $1.02M | $580.00K | — | — | 08/12/2024 | Get Alert |
CLSD | Clearside Biomedical | -$0.15 | -$0.14 | -$0.17 | -21.43% | $4.00K | $580.00K | $230.00K | -60.34% | 05/09/2024 | Get Alert |
CLSD | Clearside Biomedical | -$0.16 | -$0.09 | -$0.08 | 11.11% | $330.00K | $4.43M | $6.34M | 43.23% | 03/12/2024 | Get Alert |
CLSD | Clearside Biomedical | -$0.13 | -$0.15 | -$0.15 | 0.00% | $266.00K | $160.00K | $859.00K | 436.88% | 11/13/2023 | Get Alert |
CLSD | Clearside Biomedical | -$0.13 | -$0.14 | -$0.15 | -7.14% | $384.00K | $120.00K | $1.02M | 748.33% | 08/14/2023 | Get Alert |
CLSD | Clearside Biomedical | -$0.13 | -$0.14 | -$0.15 | -7.14% | $347.00K | $140.00K | $4.00K | -97.14% | 05/11/2023 | Get Alert |
CLSD | Clearside Biomedical | $0.31 | -$0.13 | -$0.16 | -23.08% | $25.69M | $100.00K | $330.00K | 230.00% | 03/09/2023 | Get Alert |
CLSD | Clearside Biomedical | -$0.08 | -$0.03 | -$0.13 | -333.33% | $3.07M | $6.52M | $266.00K | -95.92% | 11/09/2022 | Get Alert |
CLSD | Clearside Biomedical | -$0.11 | -$0.13 | -$0.13 | 0.00% | $780.00K | $370.00K | $384.00K | 3.78% | 08/09/2022 | Get Alert |
CLSD | Clearside Biomedical | -$0.13 | -$0.08 | -$0.13 | -62.50% | $34.00K | $2.87M | $347.00K | -87.91% | 05/11/2022 | Get Alert |
CLSD | Clearside Biomedical | -$0.14 | $0.16 | $0.31 | 93.75% | $11.00K | $17.77M | $25.69M | 44.55% | 03/10/2022 | Get Alert |
CLSD | Clearside Biomedical | -$0.05 | -$0.08 | -$0.08 | 0.00% | $3.43M | $2.58M | $3.07M | 19.15% | 11/10/2021 | Get Alert |
CLSD | Clearside Biomedical | -$0.13 | -$0.12 | -$0.11 | 8.33% | $354.00K | $690.00K | $780.00K | 13.04% | 08/10/2021 | Get Alert |
CLSD | Clearside Biomedical | -$0.07 | -$0.10 | -$0.13 | -30.00% | $4.10M | $2.12M | $34.00K | -98.40% | 05/17/2021 | Get Alert |
CLSD | Clearside Biomedical | -$0.07 | -$0.11 | -$0.14 | -27.27% | $1.94M | $1.29M | $11.00K | -99.15% | 03/10/2021 | Get Alert |
CLSD | Clearside Biomedical | -$0.17 | -$0.12 | -$0.05 | 58.33% | $141.00K | $1.82M | $3.43M | 88.57% | 11/10/2020 | Get Alert |
CLSD | Clearside Biomedical | -$0.15 | — | -$0.13 | — | $45.00K | — | $354.00K | — | 08/10/2020 | Get Alert |
CLSD | Clearside Biomedical | -$0.45 | — | -$0.07 | — | $45.00K | — | $4.10M | — | 05/08/2020 | Get Alert |
CLSD | Clearside Biomedical | -$0.68 | -$0.10 | -$0.07 | 30.00% | $30.00K | $2.95M | $1.94M | -34.17% | 03/11/2020 | Get Alert |
CLSD | Clearside Biomedical | -$0.75 | -$0.16 | -$0.17 | -6.25% | $0.00 | $10.00K | $141.00K | 1310.00% | 11/06/2019 | Get Alert |
CLSD | Clearside Biomedical | -$0.65 | -$0.39 | -$0.15 | 61.54% | $0.00 | $10.00K | $45.00K | 350.00% | 08/07/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $-0.17 | $-0.14 | -21.4 % |
Dec 2023 | 2024-03-12 | $-0.08 | $-0.09 | 11.1 % |
Sep 2023 | 2023-11-13 | $-0.15 | $-0.15 | 0.00 % |
Jun 2023 | 2023-08-14 | $-0.15 | $-0.14 | -7.14 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $230.00K | $580.00K | -60.3 % |
Dec 2023 | 2024-03-12 | $6.35M | $4.43M | 43.2 % |
Sep 2023 | 2023-11-13 | $859.00K | $160.00K | 436.9 % |
Jun 2023 | 2023-08-14 | $1.02M | $120.00K | 748.3 % |
Clearside Biomedical (CLSD) is scheduled to report earnings on August 12, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
The Actual EPS was $-0.17, which missed the estimate of $-0.14.
The Actual Revenue was $230K, which missed the estimate of $580K.
Browse earnings estimates, EPS, and revenue on all stocks.